This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to evaluate the effects of cannabis product labeling and marketing claims on consumer perceptions, use behaviors, and acute drug effects. The $689,146 award to The Johns Hopkins University will fund a multi-part study including a content analysis of cannabis product labels and marketing, an online experiment, and a placebo-controlled lab experiment....
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $686,376 to study the effects of medical cannabis use on physical and mental health outcomes in medical cannabis patients. The key objectives of the 5-year project are to: 1) examine the association between cannabis tolerance, specific cannabis effects, and the likelihood of developing a pathological pattern of cannabis use; 2) determine...
This $295,924 Project Grant award was provided by the National Institute on Drug Abuse (NIDA) under the Federal Drug Use and Addiction Research Programs (CFDA 93.279). The funding supports the development of a "WEEDetection" multi-platform detection system to identify and report illegal sales of cannabis-derived products online. The project aims to create an automated solution for monitoring social media, e-commerce, and dark web marketplaces to enable digital prevention and harm...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides funding to develop and evaluate a novel in-person brief intervention for frequent cannabis use among emerging adults. The total award amount is $205,360, with a project period from June 15, 2024 to May 31, 2029. The principal awardee is the Medical University of South Carolina, which will leverage a multidisciplinary team of mentors to...
The federal Project Grant award R01DA058041, totaling $1,427,238, was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The funding will support a 5-year prospective mixed-methods investigation at Brown University to characterize cannabis use trajectories among young adults (ages 18-25). The project aims to leverage a behavioral economics framework to understand how micro-transitions and critical life events during young...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under CFDA Program 93.279 "Drug Use and Addiction Research Programs", provides $211,988 to George Washington University (The) to conduct research on the "Socio-Structural Determinants of Cannabis and Derived Psychoactive Cannabis Product Use and Consequences Among Young Adults". The research project aims to investigate patterns of cannabis and derived cannabis product use, as well as...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $2,630,395 to The Johns Hopkins University to conduct laboratory studies investigating the impact of acute delta-9-tetrahydrocannabinol (THC) administration on the motivational, subjective, and physiological effects of combustible cigarettes and electronic cigarettes. The studies will use standardized nicotine products to determine how THC...
This federal Project Grant award for $286,984 from the National Institutes of Health's National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) will fund a randomized crossover trial to evaluate the ability of 36 regular cannabis consumers to self-titrate their THC dose when vaping cannabis concentrates of varying potencies (30%, 60%, and 90% THC). The study, conducted by the Centre for Addiction and Mental Health (CAMH) in Toronto, Canada, will characterize...
The National Institute on Drug Abuse (NIDA) awarded a $100,267 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the University of Mississippi. The grant, running from July 1, 2024 to May 31, 2029, will support research to investigate the acute and long-term effects of developmental exposure to cannabinoids, including THC and CBD, on neuroinflammation, brain development, and persistent behavioral outcomes in a zebrafish model system. The research aims to: 1)...
This federal Project Grant award from the Centers for Disease Control and Prevention's National Center for Injury Prevention and Control, under the Injury Prevention and Control Research and State and Community Based Programs (CFDA 93.136), provides $697,438 to Northwestern University to study the impact of recreational cannabis legalization on substance use outcomes. The 3-year project, titled "THE IMPACT OF RECREATIONAL CANNABIS LEGALIZATION ON SUBSTANCE USE OUTCOMES", began on...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to develop and test evidence-based cannabis warning labels to better inform the public about the harms of cannabis use. The $1,825,416 grant, awarded to the University of North Carolina at Chapel Hill, has three key objectives: 1) examine the legal and regulatory landscape of cannabis warnings in the U.S., 2) develop a set of evidence-based cannabis warnings and identify effective characteristics, and 3) determine if large cannabis warnings with promising characteristics can increase risk perceptions, knowledge, and recall of cannabis harms. The project includes a $132,760 subaward to the Public Health Law Center to conduct a legal analysis of cannabis warning regulations in U.S. states with legalized cannabis. The findings from this comprehensive research effort are intended to help regulators implement more effective cannabis warning labels that can better communicate the risks of cannabis use to the public.